{"name":"March Biosciences Inc","slug":"march-biosciences-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Genetic: MB-105","genericName":"Genetic: MB-105","slug":"genetic-mb-105","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"Genetic: MB-105","genericName":"Genetic: MB-105","slug":"genetic-mb-105","phase":"phase_2","mechanism":"Biologic","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTE54YTd6U0Z6bkhSVmR3cEFEd2lESjRaQjRpZU1paTR6T1dmQjVJTFJETkd3UXNSaGdja1NQbDFocDVaZHV0M0NyRThZT2REM1RWYldvMTJQanRiYS00NzEzVTB1Njl1bEpOQ19ST0x6cmUzTlRKZ2pOZDQtNnI?oc=5","date":"2026-03-31","type":"pipeline","source":"Fierce Biotech","summary":"Fierce Biotech Layoff Tracker 2026: Lipella, IO shutter; Takeda plots 634 US job cuts - Fierce Biotech","headline":"Fierce Biotech Layoff Tracker 2026: Lipella, IO shutter; Takeda plots 634 US job cuts","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxQYUNYU08wbXRveDNTMG9saDhrcUFCaURuanpSbkY1LTdqWVZZYVZBZ210ZlZ6NUVvVVRja05MMXJxclRsTFRCREpla3pmU2hyZ2FGS2tpRUV1d2FVTnJ6WkhDN1J3RmgxcGYtUXJwMWdZLVphaEx3Z0ZXTVBGN3hoTUFRQ3lSWlJ0X21JYjBUcWZJWERFNnpvdmpFN2ozbXBEZkRkUHVmeUUyMGN5N1FHMDFMVFpqNmtSLWNhUEZsdWRPOUww?oc=5","date":"2026-03-10","type":"pipeline","source":"PR Newswire","summary":"Neurocrine Biosciences to Present at the Stifel 2026 Virtual CNS Forum - PR Newswire","headline":"Neurocrine Biosciences to Present at the Stifel 2026 Virtual CNS Forum","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxQUU9UYzhNM3lJSV9wQVNBWWNRaExHRHhDdlBGX3RWRlg0bjdaSVllVHR6c0V4NjZYRTRHM3RhYUpNY3BCRVMxYm53RDN6N09raXFsdHdUbzZ4TmtJUGZDR01QZFUxN2RYODRQb1FPNXVrMEVyNGpfc0hFQS1LampWSEN1ME04T3NSRXB3UHhXMWdEM3JJa0taY0VfOWtBQQ?oc=5","date":"2026-03-06","type":"pipeline","source":"Stock Titan","summary":"Artelo shrinks share count to 708K in 3-for-1 reverse split - Stock Titan","headline":"Artelo shrinks share count to 708K in 3-for-1 reverse split","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxQV1EtYlVrUnVCNVkzN3FCUDNWX0lBWG1XZVdWVlMwcXVxVWJlWFhRQkVkeDBxUzdPN1d4aGRzSTZhLWthRnFaNGJ0U19YSnc1TjBzaVZiM1RJWk95NnRNNFRhcnRkR3JDTTRrSEFNVDl1V3l6djEtU0tmekJaY080em9lVFJqNjdsQlJJR1RndUdCRHFRWUl6RGdfWWw1Z3ZSZEVtQ2t3Nm0zaDNZUTdZdnBZdjd0Mnl0QU1aNg?oc=5","date":"2026-03-06","type":"pipeline","source":"GlobeNewswire","summary":"Artelo Biosciences Announces Reverse Stock Split - GlobeNewswire","headline":"Artelo Biosciences Announces Reverse Stock Split","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxNcWw4QjAtWnRtRVhZTnA1bTlibVpHalV2WnlZazlnblZuVjU5bjdzUTQxUXdaQkhseXdOUTk4YWFXLUU5d1NxeHZTNTZ3S3hHR3dwVFQtWEt3TjVxQkVxbnhuYzhXeWlLblZVTEV1ckh6cTZjTkNHZXRCWGlIQ21UaURaczFGSFZGdnYzc1RORzdCN2dITjJN?oc=5","date":"2026-03-05","type":"pipeline","source":"DCAT Value Chain Insights","summary":"Change, Change, & Change: The Pharma Industry’s Outlook & Response - DCAT Value Chain Insights","headline":"Change, Change, & Change: The Pharma Industry’s Outlook & Response","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxPOFBJY01MaEVycnVmdW85Qjg5TklSVkQ3Z1d1OGlvYnpNTGVXcDlsN0lreE5Gc3hXeXMxMWNtaUJuMFc0N2x0UlZKLUNQcXFzY2VCeHp4U2R4akhvbDhUNTFVZEgzWFN6Mk1kY2ZGTnE1TWNqRVRnNlUyTmdLeDV4MnUxVjhGWW5pNmpZdlo4MWFxWkx0LTZzZWh5OUhrZEp5aUp1dWtZc19VWnJIQmJJd0RNYXE?oc=5","date":"2026-03-04","type":"pipeline","source":"BioSpace","summary":"Acadia Pharmaceuticals Appoints Jonathan M. Poole to its Board of Directors - BioSpace","headline":"Acadia Pharmaceuticals Appoints Jonathan M. Poole to its Board of Directors","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3gFBVV95cUxOVWppOWg4dlJOUERycmRGOU1tS080Y2FTZVp3WWZSWnhVbWJjMjFXRHVIMm4ybUZqbkp6ZFllSXNQM0NNcFBHc0lMYkpRRmNmZ2xMMDRiQjB4cVdHY2J2SUhSSkpOVE1JY3lYcW5kYjJRWlJ2S2JqVFpaUXpKeEdrdFBvSnFRY0V6NDlKX0JrcGxUdXJqRVVlTkZjRkYwMFFtUTlidFVEZ28xVzhheURCSnVnWHUyVVAyNWkyV2FIdHd1WEw2LTZnRXFVZ3F0cmhIRlg1T0dsZk1Vdkd6ZWc?oc=5","date":"2026-03-02","type":"earnings","source":"Investing News Network","summary":"Nuvation Bio to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on March 2, 2026 - Investing News Network","headline":"Nuvation Bio to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on March 2, 2026","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxQYzRwcjdpUFZvaEJ1QnNtVHVROUpNbndlOHlyOFNQdS0wQWJVQkFVdU9uamZPYlZSeW9DQWMzaXNvSVNhUUtWNDRCR0xBNFBGV0JpSWxxYS1vaGctZ0cwZW5pMGlEUFFLeERCZFVmQUNVYjFaWk9QRV9nY01Qajc2ZHVXaTRwSXVHSks5NDM2azQ?oc=5","date":"2026-01-07","type":"pipeline","source":"BioPharma Dive","summary":"Lilly snaps up Ventyx for $1.2B in pursuit of oral immune drugs - BioPharma Dive","headline":"Lilly snaps up Ventyx for $1.2B in pursuit of oral immune drugs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTE9iVUFUYkF6aGt3akxZT0hGaW1LLTVITDlQdFFCYUZkc2IwaDJKSHZpQ1d2VmtPWldraV9yWm9idUZab0xqcWZzdXllQ1BIaF9WUGVxcFJMNWhPakFld2QzRVg2dElTbkZjVjdzcEY3QmtFRG96SzhTT25aMkY?oc=5","date":"2025-12-17","type":"pipeline","source":"Fierce Biotech","summary":"Fierce Biotech Layoff Tracker 2025: Voyager jettisons 30 staffers; Mythic and Areteia shutter - Fierce Biotech","headline":"Fierce Biotech Layoff Tracker 2025: Voyager jettisons 30 staffers; Mythic and Areteia shutter","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxOQmM2b2RJZmUtUktYNER0dTVQSTRxb180YUdLWGFxaDlLMmdBX0kxWi1fUU1RS3hhNHEzUUxBaDkxSHpnNDY0bWt3OGZFSUVIdnJ3V043RVNiemg4YzFILXhUdXAtUGo5NFlydUl2WlBrZ2Y4czRQNWstNVAtWUsxaDI5ZG8?oc=5","date":"2025-12-04","type":"pipeline","source":"DCAT Value Chain Insights","summary":"2025: The Bio/Pharma Industry’s Year in Review - DCAT Value Chain Insights","headline":"2025: The Bio/Pharma Industry’s Year in Review","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZkFVX3lxTE4tY0V6UjMwN3VrWHhScmdKUHZpMzlDRDA1cnVGY1ZMak96a2hVdnA5RVZCZ3EzSUd4RFFIM3ZIRTdUamFnUExZTV9HaGJ0bGNhbkc1QjlkNmRVeldFdWd4d2ZoZ2tpUQ?oc=5","date":"2025-11-13","type":"pipeline","source":"InnovationMap","summary":"InnovationMap Editor - InnovationMap","headline":"InnovationMap Editor","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwJBVV95cUxPSHFvcVNsQjc0TzFEUFRRUWZ4UF9uYkpmZWdpd1h4NWJHS1RpOU9aSWRFZ0NHaURPYlpQODNLQlVoSkpvZDVGZ19fcksteVppLW1VU1NYdzMxa0tRR2wwOVBBaXVzV3F0UnZNdXBMUE5YQURPSEE1Yl90dUVkcjUtd0g3bGNoNE91ZmxDNHhGVW5GenZpdHRCMl9xY0ZraTRKdFBHSkNtU2pteTZVRnpYN0sydGVsa0pKYm91bmF4SjN1cDJfTzJoQ25VdERMd1RseEZoZ19DOUdIeFJydzF4TW5DNkxEd3Y2azJvNGNUUnhVSjVOQm9icDFmTm1jQUJ0b2tSY0xwMFp2UC1wMXlITlBxU2hXNE1aMUZUN0V3ZkVZcTFfMnNGOV9Zb1BjbURkNVpSLXhTc1Q5c1p1S25URjRpMA?oc=5","date":"2025-11-11","type":"regulatory","source":"GlobeNewswire","summary":"March Biosciences Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for MB-105 in Relapsed/Refractory CD5-Positive T-Cell Lymphoma - GlobeNewswire","headline":"March Biosciences Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for MB-105 in Relapsed/Refracto","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}